MediPal Holdings Corporation
MEPDF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.82B
Close$
$43.65
133.9% upside
Current Fair Value
133.9% upsideUndervalued by 133.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.82 Billion |
|---|---|
| Enterprise Value | $-241,244,634,660.00 |
| Annual dividend | $0.43 |
| Dividend yield | 2.43% |
| Earnings per Share | $207.71 |
| Beta | -0.02 |
| Outstanding Shares | 204,699,000 |
Return
| Return on Equity | 7.34% |
|---|---|
| Return on Assets | 2.46% |
| Return on Invested Capital | 8.61% |
Valuation & Multiples
| P/E Ratio | 14.11 |
|---|---|
| PEG | 31.91 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 0.1 |
| Enterprise Value to EBIT | 5.67 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$0.28
Consensus analyst estimateRevenue Estimate
$5.96 B
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$0.44
Consensus analyst estimateRevenue Estimate
$6.26 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About MediPal Holdings Corporation
13,024 employees
CEO: Shuichi Watanabe
Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898, primarily specializes in the wholesale distribution of prescription pharmaceuticals throughout Japan. The firm procures a broad spectrum of healthcare products, ...